| Gene symbol | E7 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_001526.4 (7604..7900) | dbXrefs | |
| Description | transforming protein E7 | ||||
| GTO ID | GTC3843 |
| Trial ID | NCT06358053 |
| Disease | Cervical Cancer | Anal Cancer | Head and Neck Cancer |
| Altered gene | HPV16 E7 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | CRTE7A2-01 TCR-T cells |
| HLA | HLA-A*02:01 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Phase I Study to Evaluate the Safety, Tolerance and Efficacy of CRTE7A2-01 TCR-T Cells in HLA-A*02:01+ Subjects With HPV16 Positive Advanced Cervical, Anal, or Head and Neck Cancers and Other Solid Tumors |
| Year | 2024 |
| Country | China |
| Company sponsor | Corregene Biotechnology Co., Ltd |
| Other ID(s) | CRTE7A2-2302C |
| Cohort 1 | |||||||||
|
|||||||||